ANTI-ITCH (HC) (hydrocortisone)
TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
CHAIN DRUG
Indication
Contact dermatitis
Contact dermatitis is an acute or chronic inflammatory skin disorder triggered by direct cutaneous exposure to exogenous substances. Read more about Contact dermatitis
1,175 drugs 319 manufacturers
Drugs that treat it
Common Contact dermatitis therapies.
ANTI-ITCH (HC) (hydrocortisone)
TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
EQUALINE VITAMI
ANTI-ITCH (HC) (hydrocortisone)
TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
EQUALINE VITAMI
ANTI-ITCH (HC) (hydrocortisone)
TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
Walgreen Co
MILLIPRED (prednisolone)
TRICHINOSIS·+59
AVALO THERAPEUT
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Parke-Davis Pfizer
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Laboratories Div
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Pharmacia & Upjohn Company
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Parke-Davis Pfizer
Filter & compare in the drug finder →Opens the drug finder with Contact dermatitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonContact dermatitis is an acute or chronic inflammatory skin disorder triggered by direct cutaneous exposure to exogenous substances.
It primarily affects the integumentary system across all age groups and is broadly classified into irritant contact dermatitis and allergic contact dermatitis.
Irritant contact dermatitis involves non-immunologic physical or chemical disruption of the epidermal barrier, whereas allergic contact dermatitis is a delayed-type (type IV) hypersensitivity reaction mediated by allergen-primed T lymphocytes.
Clinically, the condition manifests with well-demarcated pruritus, erythema, edema, and vesiculation in acute phases, often progressing to lichenification, xerosis, and scaling with chronic exposure.
- nih.gov
Contact dermatitis is an acute or chronic inflammatory skin disorder triggered by direct cutaneous exposure to exogenous substances
- nih.gov
Contact dermatitis is an acute or chronic inflammatory skin disorder triggered by direct cutaneous exposure to exogenous substances It primarily affects the integumentary system across all age groups and is broadly classified into irritant contact dermatitis and allergic contact dermatitis Irritant contact dermatitis involves non-immunologic physical or chemical disruption of the epidermal barrier, whereas allergic contact dermatitis is a delayed-type (type IV) hypersensitivity reaction mediated...
- nih.gov
Contact dermatitis is an acute or chronic inflammatory skin disorder triggered by direct cutaneous exposure to exogenous substances
- nih.gov
It primarily affects the integumentary system across all age groups and is broadly classified into irritant contact dermatitis and allergic contact dermatitis
- nih.gov
Irritant contact dermatitis involves non-immunologic physical or chemical disruption of the epidermal barrier, whereas allergic contact dermatitis is a delayed-type (type IV) hypersensitivity reaction mediated by allergen-primed T lymphocytes
- medlineplus.gov
Clinically, the condition manifests with well-demarcated pruritus, erythema, edema, and vesiculation in acute phases, often progressing to lichenification, xerosis, and scaling with chronic exposure
Personalize your experience
Follow Contact dermatitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.